I thank you for your answer.
I submit your hints to my physician along a small dossier on EXISULIND (from cellpathways.com) and ARGLADIN (from NUONCOLOGY).
The following two problems arose:
1) italian oncologist have no experience with the two drugs
2) arglabin is not available in Italy
I can try to manage the second problem asking Saaed Kashkimbayed of [url="http://www.ec21.net."]www.ec21.net.[/url]
For what concern the first problem could you suggest a possible protocol which provide:
a) how much of clinoril, mevacor, arglabin, 2ME2 and oral copper have to be assumed?
b) how frequent clinoril, mevacor, arglabin, 2ME2 and oral copper are to be assumed.
In case you know that the above drugs are used somewhere in Italy or Europe, please let me to know.
Finally consider that in Italy, as may be in your country too, physicians are responsible of their actions so they cannot apply protocols which are not explicitly allowed from the local health autority.
This may push me to do myself. I hope you can support me in this action.
In case you consider more appropriate to be directly in touch, let me know. I will ask HealthBoard to communicate you my e-mail address.